These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11428932)

  • 21. The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses.
    Micheletti F; Bazzaro M; Canella A; Marastoni M; Traniello S; Gavioli R
    Immunology; 1999 Mar; 96(3):411-5. PubMed ID: 10233722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design.
    Zhang J; Yang J; Fan D; Tao H; Wang H; Yu T
    Oncol Rep; 2013 May; 29(5):1955-61. PubMed ID: 23503586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications.
    Dela Cruz CS; Tan R; Rowland-Jones SL; Barber BH
    Int Immunol; 2000 Sep; 12(9):1293-302. PubMed ID: 10967024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
    J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8.
    Ribechini E; Fortini C; Marastoni M; Traniello S; Spisani S; Monini P; Gavioli R
    J Immunol; 2006 Jan; 176(2):923-30. PubMed ID: 16393977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen.
    van Elsas A; van der Burg SH; van der Minne CE; Borghi M; Mourer JS; Melief CJ; Schrier PI
    Eur J Immunol; 1996 Aug; 26(8):1683-9. PubMed ID: 8765006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity.
    Keogh E; Fikes J; Southwood S; Celis E; Chesnut R; Sette A
    J Immunol; 2001 Jul; 167(2):787-96. PubMed ID: 11441084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206.
    Torikai H; Akatsuka Y; Miyauchi H; Terakura S; Onizuka M; Tsujimura K; Miyamura K; Morishima Y; Kodera Y; Kuzushima K; Takahashi T
    Bone Marrow Transplant; 2007 Jul; 40(2):165-74. PubMed ID: 17530010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope.
    Ostankovitch M; Guichard G; Connan F; Muller S; Chaboissier A; Hoebeke J; Choppin J; Briand JP; Guillet JG
    J Immunol; 1998 Jul; 161(1):200-8. PubMed ID: 9647225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
    Sarobe P; Pendleton CD; Akatsuka T; Lau D; Engelhard VH; Feinstone SM; Berzofsky JA
    J Clin Invest; 1998 Sep; 102(6):1239-48. PubMed ID: 9739058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.
    Brooks JM; Murray RJ; Thomas WA; Kurilla MG; Rickinson AB
    J Exp Med; 1993 Sep; 178(3):879-87. PubMed ID: 7688791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.
    Hoffmann TK; Nakano K; Elder EM; Dworacki G; Finkelstein SD; Appella E; Whiteside TL; DeLeo AB
    J Immunol; 2000 Nov; 165(10):5938-44. PubMed ID: 11067956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
    Murray RJ; Brooks JM; Rickinson AB; Rowe M
    Eur J Immunol; 1990 Mar; 20(3):659-64. PubMed ID: 1690661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine.
    Brander C; Pichler WJ; Corradin G
    Clin Exp Immunol; 1995 Jul; 101(1):107-13. PubMed ID: 7621579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kinetics of peptide binding to HLA-A2 and the conformation of the peptide-A2 complex can be determined by amino acid side chains on the floor of the peptide binding groove.
    Shimojo N; Anderson RW; Mattson DH; Turner RV; Coligan JE; Biddison WE
    Int Immunol; 1990; 2(3):193-200. PubMed ID: 2088485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.